OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Pulmonary Medicine is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	45
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	38
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	31
The persistent problem of persistent air-leaks: approach to management	30
Home monitoring in asthma: towards digital twins	27
Bronchoscopic treatment of early-stage peripheral lung cancer	27
The role of PET in the management of sarcoidosis	26
Improving care in lung cancer surgery: a review of quality measures and evolving standards	24
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	23
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	20
Digital outcome measures in pulmonary clinical trials	18
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	18
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	17
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	16
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	16
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	15
Considerations and clinical management of infections in sarcoidosis	15
Group 2 pulmonary hypertension: from diagnosis to treatment	15
Implementation of digital home monitoring and management of respiratory disease	15
Bronchoscopic diagnosis of peripheral lung lesions	15
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	14
Lung transplant referral considerations for individuals with cystic fibrosis	14
Editorial introductions	14
Editorial introductions	14
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	14

Asthma in pregnancy: a review of recent literature	14
Progress for all: addressing disparities in sarcoidosis	13
The future of clinical trials in idiopathic pulmonary fibrosis	13
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	13
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	12
Cystic fibrosis liver disease in the post-modulator era	12
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	12
Tobacco treatment in the setting of lung cancer screening	12
What causes cough in pulmonary fibrosis, and how should we treat it?	12
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	12
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	12
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	12
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	12
Casting light on the many facets of sarcoidosis	12
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	11
Digital inhalers for asthma management	11
Imaging in peripheral bronchoscopy	11
Acute rejection post lung transplant	11
Home monitoring of coronavirus disease 2019 patients in different phases of disease	11
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	11
Novel insights in fibrotic pulmonary sarcoidosis	10
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	10
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	10
Patterns of progression in non-IPF fibrotic interstitial lung disease	10
Effectiveness and safety of coronavirus disease 2019 vaccines	10
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	10
Editorial: Are we ready for prime time?	10
Multidisciplinary care in nonmalignant central airway obstruction	9
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease	9
Exhaled breath analysis in interstitial lung disease	9
Epigenetics and aging: relevance for sleep medicine	9
Telerehabilitation in pulmonary diseases	9
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	9
Infection control in cystic fibrosis: evolving perspectives and challenges	9
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	9
Right ventricular assessment in pulmonary hypertension	8
The changing landscape of infections in the lung transplant recipient	8
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	8
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	8
Adenotonsillectomy: the good, the bad and the unknown	8
Editorial: ‘What is your occupation?’: historical snippets	8
The association of preexisting severe asthma with COVID-19 outcomes	8
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	8
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	8
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	8
Ergonomics in bronchoscopy	8
Altered pharmacology and toxicology during ageing: implications for lung disease	8
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	8